New products are live, and we’ve lowered prices across the catalog. Heads up - high demand means a 2–3 day shipping backlog. Free shipping on orders over $200!
Palm Beach Vitality

Cagrilintide 10mg Pen

$112.00

Cagrilintide 3 mL Pen

The Science, Simplified: Cagrilintide is a long-acting synthetic amylin analog.

Product Specifications – Cagrilintide 10 mg 3 mL Pen

  • Total Cagrilintide: 10 mg
  • Volume: 3 mL pre-filled pen
  • Concentration: ≈3.33 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use multi-use pre-filled pen

Key Research Focus: Amylin-pathway laboratory research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Pen Format Details: The 3 mL pre-filled pen is a multi-use system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge and dial mechanism for accurate volume control. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 4–6 weeks when protected from light and handled with clean laboratory technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 6 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.

Research Use Only

For laboratory research use only (RUO). Not for human use, veterinary use, household use, or consumption. Not a drug, food, supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Buyer represents they are a qualified researcher purchasing for lawful research purposes only.

Specs-forward listing for Cagrilintide: 10 mg in a 3 mL research pen for amylin-pathway laboratory models. Ready-to-use; lot COA available.

Cagrilintide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Cagrilintide research overview

  1. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialPubMed 34798060
  2. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight managementPubMed 33894838
  3. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesPubMed 40544432
  4. Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2)PubMed 42251859
  5. Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on metforminPubMed 42251860
Cagrilintide amino acid chain
Cagrilintide — amino acid chain (N→C)